Photo caption: Distinguished Professor Geoff Chase (left) and Dr Lui Holder-Pearson (right) explore new technology to ease pressure on ICUs.
ICU spending accounts for around 1% of New Zealand's Gross Domestic Product and approximately 10% of the country's total healthcare expenditure. As demand for healthcare continues to outpace funding and resources, the pressure on ICUs is intensifying.
University of Canterbury (UC) | Te Whare Wānanga o Waitaha researchers Distinguished Professor Geoff Chase and Dr Lui Holder-Pearson aim to boost ICU productivity through digitally-led, personalised, and automated care, using world-leading Digital Twin (DT) and Digital Cockpit technologies.
"We are at a tipping point in being able to provide quality healthcare for everyone. What we do next will be key," Distinguished Professor Chase says.
"Despite growing demand and abundant data from medical devices and systems, healthcare still lacks effective automation. Effective healthcare automation hinges on accurately predicting how patients will respond to treatment."
Distinguished Professor Chase says the portion of healthcare costs not funded by the government, and instead borne by New Zealanders, grows by 4-5% annually.
His research team aims to tackle two major challenges to ICU efficiency: the lack of a central system to access and manage data from medical sensors and devices, and the absence of validated DT models that can predict how individual patients will respond to treatment.
"Our research programme will develop both the foundational automation platform - our Digital Cockpit - and state-of-the-art, clinically validated, natively integrated DT applications that, together, will unlock healthcare automation."
Distinguished Professor Chase says Health DTs are a digital model of someone's response to care. They use available data to guide care in real time and accurately predict how someone will respond to treatment to optimise outcomes. A Digital Cockpit will turn the paper sheets used at hospital bedsides into a digital format. This will allow automated use of approved medical devices that can easily work together.
Distinguished Professor Chase believes this research programme could put New Zealand at the forefront of the emerging MedTech industry and deliver significant economic benefits by reducing Health/ACC costs and improving patient outcomes.
This research is a collaboration with the UC Centre for Good Work, the Johner Institute, the Auckland Bioengineering Institute and Taiuru Associates.
